MINIMAL RESIDUAL DISEASE (MRD) ANALYSIS FOR T-ALL
Rs 18,225 Rs 13,500
26 % OFF
DETECTION OF MINIMAL RESIDUAL DISEASE IN ACUTE LYMPHOBLASTIC LEUKEMIA PREDICTS OUTCOME. THIS ASSAY HELPS TO IDENTIFY PATIENTS AT HIGHER/LOWER RISK OF RELAPSE. DETECTION OF MINIMAL RESIDUAL DISEASE IS IMPORTANT FOR RISK ASSESSMENT AND STRATIFICATION OF THERAPY. IT DETECTS SUB MICROSCOPIC LEVELS OF LEUKEMIA WITH A CLINICAL SENSITIVITY OF 0.01%.
Why book with us?
-
Free and On Schedule Sample Collection
-
24/7 Service
-
Affordable
-
Quick and Accurate Reports
3 ML (1 ML MIN.) FIRST PULL BONE MARROW ASPIRATE IN 1 GREEN TOP (SODIUM HEPARIN) TUBE AND 4 ML (3 ML MIN.) WHOLE BLOOD IN 1 GREEN TOP (SODIUM HEPARIN) TUBE. SHIP IMMEDIATELY AT 18-22 C. DO NOT REFRIGERATE OR FREEZE. IT IS MANDATORY TO PROVIDE DATE & TIME OF SAMPLING, PREVIOUS IMMUNOPHENOTYPE REPORT & CLINICAL HISTORY. ALL INFORMATION SHOULD BE GIVEN AT THE TIME OF REGISTRATION/BEFORE THE SAMPLE IS PROCESSED.
FLOW CYTOMETRY
REPORT ON 4TH DAY EVENING 7PM
IT IS MANDATORY TO PROVIDE DATE & TIME OF SAMPLING, PREVIOUS IMMUNOPHENOTYPE REPORT & CLINICAL HISTORY.
